While we cannot exclude that medications may have contributed, at least in part, to the decrease of the CCR2 + CCR5 + cells effector memory T cells in RA patients, we did not observe a significant decrease in other populations that also coexpress CCR2 and CCR5. This evidence concerns the gene CCR5 and rheumatoid arthritis.